Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 23, Issue 4, 2000, Pages 321-326

  Tang, Alice M ^a,b   Smit, Ellen ^a   Semba, Richard D ^c   Shah, Nina ^a   Lyles, Cynthia M ^a,d   Li, Dongguang ^a   Vlahov, David ^a,e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e NEW YORK ACADEMY OF MEDICINE   (United States)

Author keywords

Antioxidants; Antiretroviral treatment; Carotenoids; HIV infection; Protease inhibitors; Tocopherols

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ANTIRETROVIRUS AGENT; BETA CAROTENE; CRYPTOXANTHIN; GAMMA TOCOPHEROL; LYCOPENE; PROTEINASE INHIBITOR; RETINOL; XANTHOPHYLL; ZEAXANTHIN;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0034176276     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200004010-00006     Document Type: Article

References (23)

1. Allard JP, Aghdassi E, Chau J, et al. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. Am J Clin Nutr 1998;67:143-7.
2. Cirelli A, Ciardi M, De Simone C, et al. Serum selenium concentration and disease progress in patients with HIV infection. Clin Biochem 1991;24:211-14.
3. Constans J, Peuchant E, Pellegrin JL, et al. Fatty acids and plasma antioxidants in HIV-positive patients: correlation with nutritional and immunological status, Clin Biochem 1995;28:421-6.
4. Favier A, Sappey C, Leclerc P, et al. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem-Biol Interact 1994;91:165-80.
5. Lacey CJ, Murphy ME, Sanderson MJ, et al. Antioxidant-micronutrients and HIV infection. Int J STD AIDS 1996;7:485-9.
6. Look MP, Rockstroh UJK, Rao GS, et al. Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection. Eur J Clin Nutr 1997;51: 266-72.
7. Malvy DJM, Richard MJ, Arnaud J, et al. Relationship of plasma malondialdehyde, vitamin E and antioxidant micronutrients to human immunodeficiency virus-1 seropositivity. Clin Chim Acta 1994;224:89-94.
8. Phuapradit W, Chaturachinda K, Taneepanichskul S, et al. Serum vitamin A and β-carotene levels in pregnant women infected with human immunodeficiency virus-1. Obstet Gynecol 1996;87:564-7.
9. Skumick JH, Bogden JD, Baker H, et al. Micronutrient profiles in HIV-1-infected heterosexual adults. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:75-83.
10. Baier-Bitterlich G, Fuchs D, Wachter H. Chronic immune stimulation, oxidative stress, and apoptosis in HIV infection. Biochem Pharmacol 1997;53:755-63.
11. Baruchel S, Wainberg MA. The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J Leuk Biol 1992;52:111-14.
12. Pace GW, Leaf CD. The role of oxidative stress in HIV disease. Free Rad Biol Med 1995;19:523-8.
13. Vlahov D, Anthony JC, Munoz A, et al. The ALIVE study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. J Drug Issues 1991;21:759-76.
14. Sowell AL, Huff DL, Yeager PR, et al. Simultaneous determination of retinol, α-tocopherol, lutein/zeaxanthin, β-cryptoxanthin, lycopene, trans-β-carotene, and four retinyl esters in serum by reversed-phase high-performance liquid chromatography with multi-wavelength detection. Clin Chem 1994;40:411-16.
15. Schakel SF, Sievert YA, Buzzard IM. Sources of data for developing and maintaining a nutrient database. J Am Diet Assoc 1988; 88:1268-71.
16. Celentano DD, Vlahov D, Cohn S, et al. Self-reported antiretroviral therapy in injection drug users. JAMA 1998;280:544-6.
17. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-8.
18. Miller KD, Jones E, Yanovski JA, et al. Visceral abdominal-fat accumulation associated with use of Indinavir. Lancet 1998;351: 871-5.
19. Vatassery GT, Krezowski AM, Eckfeldt JH. Vitamin E concentrations in human blood plasma and platelets. Am J Clin Nutr 1983; 37:1020-4.
20. Hunter D. Biochemical indicators of dietary intake. In: Willett W. Nutritional epidemiology, 2nd ed. ed. New York: Oxford University Press, 1998:174-243.
21. Gibson RS. Principles of nutritional assessment. New York, Oxford University Press, 1990:397-404.
22. Greenspan HC, Aruoma OI. Oxidative stress and apoptosis in HIV infection: a role for plant-derived metabolites with synergistic antioxidant activity. Immunol Today 1994;15:209-13.
23. Halliwell B, Cross CE. Reactive oxygen species, antioxidants, and acquired immunodeficiency syndrome. Arch Intern Med 1991;151: 29-31.